Shingles from reactivation of herpes zoster is a significant problem for patients with autoimmune diseases but a small trial of live attenuated zoster vaccine in people with systemic lupus erythematosus (SLE) has raised hope that vaccination may be possible for this group. Patients with SLE are ten times more likely to develop shingles than healthy ...
Zoster vaccination may be feasible for lupus patients
By Ingrid Torjesen
19 Jun 2018